Correction to “Design, Synthesis, and Structure–Activity Relationship

This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Addition/Correction pubs.acs.org/jmc

Correction to “Design, Synthesis, and Structure−Activity Relationship of a Novel Series of GluN2C-Selective Potentiators” Sommer S. Zimmerman, Alpa Khatri, Ethel C. Garnier-Amblard, Praseeda Mullasseril, Natalie L. Kurtkaya, Stefka Gyoneva, Kasper B. Hansen, Stephen F. Traynelis,* and Dennis C. Liotta* Journal of Medicinal Chemistry 2014, 57, 2334−2356. DOI: 10.1021/jm401695d Page 2341. Compound 162 in Table 4 has been misrepresented as having a methyl group in the R1 position when there should be an isonicotinoyl group. Page 2345. Compounds 159 and 160 in Table 8 should be drawn as having a methyl group in the 2-postion of the indole and the R1 should be a methyl group instead of the nicotinoyl group as shown. Pages 2344−2355. In the section “Chemistry Experimentals”, the above-mentioned compounds do have the correct names and characterization. After rechecking the purity of all of the reported compounds, it was found that compounds 66, 67, 68, 85, 89, 90, 100, and 112 did not meet the J. Med. Chem. purity standards.

Published: March 4, 2015 © 2015 American Chemical Society

2862

DOI: 10.1021/acs.jmedchem.5b00199 J. Med. Chem. 2015, 58, 2862−2862